Orn8, Urotensin II, human CAS NO.479065-85-5

<p>Orn⁸, Urotensin II (human) (CAS NO. 479065-85-5) is a synthetic, site-specifically modified analog of human Urotensin II (U-II), a potent vasoactive cyclic neuropeptide. This research-grade analog features the substitution of the native cysteine at position 8 with ornithine (Orn), disrupting the ability to form the characteristic disulfide bridge. This linearized analog is a crucial tool for investigating the rol…

SupplierGlobal Technology Co., Ltd.www.hqtechtirz.com

View on supplier website More from this supplier

Source categories

Peptides

About this product

Product information from the supplier.

TECHNICAL SPECIFICATIONS

Item	Specification
Product Name	Orn8, Urotensin II, human
CAS NO.	479065-85-5
Appearance	White to off-white lyophilized powder
Molecular Formula	C63H85N13O18S2
Molecular Weight	1376.6/mol
Purity (RP-HPLC)	≥98%
Solubility	Soluble in water (up to 5 mg/mL), dilute acetic acid, or DMSO; also soluble in aqueous buffers
Endotoxin	≤1.0 EU/mg
Biological Activity	Potent agonist of the urotensin II receptor (UT receptor).
Storage Conditions	Store desiccated at -20°C to -80°C; avoid repeated freeze-thaw cycles. Stable for 2–3 years under proper storage.
Stock Location	Stock in USA
MOQ	1g

1.MECHANISM OF ACTION

This linear analog acts as a ligand for the G protein-coupled urotensin-II receptor (UT receptor). The substitution of Cys⁸ with Orn⁸ prevents the formation of the intramolecular disulfide bond, forcing the peptide into a linear conformation. This structural change typically results in a significant reduction or complete loss of the potent vasoconstrictor and cardiorenal effects associated with native cyclic U-II. It functions as a weak agonist or antagonist, providing a means to study the structural requirements for UT receptor activation and to probe receptor-ligand interactions.

2.PRODUCT INDICATIONS

This product is indicated for advanced research in cardiovascular pharmacology, peptide chemistry, and receptor biology. Key applications include: studying the importance of the cyclic structure and specific residues for U-II's biological potency and receptor binding affinity; serving as a negative control or antagonist-like ligand in vascular contraction assays; exploring the structure-activity relationship (SAR) of U-II analogs; and as a precursor for the development of novel linear UT receptor modulators for potential therapeutic intervention in cardiovascular diseases.

3.CLINICAL EFFICACY OF PRODUCT

Orn⁸ Urotensin II is a specialized research compound, not a clinical therapeutic. Its efficacy lies in its role as a definitive scientific tool for understanding U-II's structure-function relationship. Studies using this linearized analog have conclusively demonstrated that the cyclic conformation is essential for U-II's extreme potency.

4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.